Nrf2 drives activation-driven expansion of CD4(+)T cells by modulating glucose and glutamine metabolism
Recommended Citation
Tripathi A, Dasgupta D, Dahabieh MS, Griffard-Smith R, Pant A, Bugbee A, Yellapu NK, Burt E, Choi BHY, Ellis AE, Sheldon RD, Giri S, Koestler D, Jones RG, Yadav VN, and Pyaram K. Nrf2 drives activation-driven expansion of CD4(+)T cells by modulating glucose and glutamine metabolism. Cell Rep 2025;44(9):116177.
Document Type
Article
Publication Date
9-23-2025
Publication Title
Cell Rep
Abstract
Upon antigenic stimulation, CD4(+)T cells undergo clonal expansion elevating their bioenergetic demands and utilization of nutrients like glucose and glutamine. The nuclear factor erythroid-2-related factor 2 (Nrf2) is a well-known regulator of oxidative stress, but its involvement in modulating the metabolism of CD4(+)T cells remains unexplored. We report that Nrf2 protein levels are temporally regulated in activated CD4(+)T cells, with elevated expression during early activation followed by a decline. T cell-specific constitutive activation of Nrf2, by deletion of its negative regulator Keap1, enhances early activation and interleukin-2 (IL-2) expression, upregulates T cell receptor (TCR) signaling, and increases activation-driven expansion of CD4(+)T cells. Mechanistically, elevated Nrf2 activity in activated CD4(+)T cells increases chromatin accessibility and proliferation-associated gene expression. Metabolically, high Nrf2 alters glucose metabolism and promotes glutamine metabolism via glutaminolysis to support CD4(+)T cell hyperproliferation. In summary, we elucidate the role of Nrf2 beyond traditional antioxidation in modulating the activation-driven expansion of CD4(+)T cells by influencing their nutrient metabolism and gene expression.
Medical Subject Headings
NF-E2-Related Factor 2; Glutamine; CD4-Positive T-Lymphocytes; Glucose; Animals; Mice; Lymphocyte Activation; Cell Proliferation; Kelch-Like ECH-Associated Protein 1; Mice, Inbred C57BL; Receptors, Antigen, T-Cell; Signal Transduction; Interleukin-2
PubMed ID
40857154
Volume
44
Issue
9
First Page
116177
Last Page
116177
